ABSTRACT
Ryanodine receptors (RyRs) are large, high conductance Ca 2+ channels that control the level of intracellular Ca 2+ by releasing Ca 2+ from an intracellular compartment, the sarco/endoplasmic reticulum. Mammalian tissues express 3 closely related ryanodine receptors (RyRs) known as skeletal muscle (RyR1), cardiac muscle (RyR2) and brain (RyR3) . The RyRs are isolated as 30S protein complexes comprised of four 560 kDa RyR2 subunits and four 12.6 kDa FK506 binding protein (FKBP12.6) subunits.
Multiple endogenous effector molecules and posttranslational modifications regulate the RyRs. This chapter reviews the regulation of the mammalian RyRs by endogenous effector molecules.
INTRODUCTION
Ryanodine receptors (RyRs) are large, high conductance Ca 2+ channels that control the level of intracellular Ca 2+ by releasing Ca 2+ from an intracellular compartment, the sarco/endoplasmic reticulum. They are known as ryanodine receptors because they bind the plant alkaloid ryanodine with high affinity and specificity and to distinguish them from another intracellular Ca 2+ release channel family, the inositol 1,4,5-tris phosphate receptors (IP 3 R). There are three widely expressed mammalian RyR isoforms: RyR1 is the dominant isoform in skeletal muscle, RyR2 is found in high levels in cardiac muscle, and RyR3 is expressed in many tissues at low levels including diaphragm and brain. They are also known as skeletal muscle (RyR1), cardiac muscle (RyR2) and brain (RyR3) RyRs because they were first isolated from these tissues. All three have been purified as 30 S protein complexes composed of four 560 kDa subunits and four small 12 kDa FK506 binding proteins (FKBP) with a total molecular weight of ~2,200 kDa (Table 1) . They are cation-selective channels that have high conductance for mono-and divalent cations and are regulated by a large number of endogenous and exogenous effectors. Ca 2+ ions are the principal activators of the cardiac and brain isoforms. In cardiac muscle during an action potential, dihydropyridineand voltage-sensitive (L-type) Ca 2+ channels (DHPRs) located in the surface membrane and tubular infoldings of the surface membrane (T-tubule) mediate the influx of Ca 2+ that open SR Ca 2+ release channels. Regulation of the skeletal isoform differs significantly from that of the two other isoforms. A unique property of the mammalian skeletal muscle RyR is that its activity is regulated via direct protein-protein interactions with the voltage-sensing T-tubule L-type Ca 2+ channel/dihydropyridine receptor. Morphological evidence indicates the presence of a second population of RyR1s in mammalian skeletal muscle that are not directly linked to L-type Ca 2+ channels, which raises the question how unlinked RyRs are activated. One suggestion is that Ca 2+ ions released by DHPR-linked Figure 2) , suggesting that the carboxyl-terminal region (3720-5037) has a role in Ca 2+ inactivation. The mutation studies are complicated because mutations may induce long-range conformational changes that distort the assembly of the large multimeric RyR complexes. A distinguishing feature of mammalian RyRs is that at 0.25 -0.5 M KCl, Ca 2+ ions activate RyR2 ( Figure 2 ) and RyR3 (6-8) to a greater extent than RyR1. A lower binding affinity of Ca 2+ to the Ca 2+ inactivation sites of RyR2 and RyR3 appears to be the primary cause. As observed for RyR1, monovalent cations had an inhibitory effect on RyR2 by interacting with the Ca 2+ activation and inactivation sites. Cl -had an activating effect (20). Modulation of mammalian RyR3 activity by monovalent cations and anions has not been systematically studied. 2+ , suggesting that the low-affinity inhibitory site has a broad divalent cation specificity. On the other hand, ionic strength affected the efficacy of divalent cations in inhibiting RyR1, as indicated by an inactivation constant of ~0.1 and ~1.35 mM in 0.1 mM and 0.5 mM KCl media, respectively (21). 
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3 H]ryanodine binding, effects not observed for RyR1. A conformational change in the purified receptor rather than removal of a necessary cofactor may be responsible for the lack of function. Single channel measurements showed that application of a transmembrane potential restored channel inhibition by CaM (39). Direct binding of CaM to the native RyR3 was not reported since no tissue expresses RyR3 alone.
OXIDATION OF RYRS
Working skeletal muscle produces reactive oxygen intermediates (44). Reactive oxygen intermediates are also extensively formed during reoxygenation of ischemic tissue and include superoxide, hydroxyl radicals and hydrogen peroxide. In support of a functional role of these compounds, redox-active compounds and antioxidant enzymes modulate excitation-contraction coupling and force production in striated muscle.
RyR1 is an excellent target for reactive oxygen intermediates formed in muscle because it contains a large number of free sulfhydryls. (46) . Channel closing at <µM Ca 2+ or mM Ca 2+ or Mg 2+ caused the redox potential to become less negative, favoring the formation of free thiols. Highly reactive (hyperreactive) thiols help to confer Ca 2+ sensitivity because a redox response was no longer observed when the closed channel was pretreated with 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin (CPM), an alkylating reagent, that specifically labels RyR1 at nM concentrations. In single channel measurements, RyR1 responded to redox potentials produced by SR lumenal and cytoplasmic glutathione, indicating the presence of a unique transmembrane redox sensor in RyR1 (47) . An SR transporter selective for glutathione was identified and the involvement of hyperreactive thiols in the function of the transmembrane redox sensor in RyR1 was described (47) .
Studies have attempted to identify the cysteines involved in redox modulation of the RyRs. NEN alkylation and diamide oxidation of skeletal muscle SR membranes and trypsin digestion suggested that C3635 is involved in redox and calmodulin modulation of RyR1 activity (48) . On the other hand, while a C3635 to alanine substitution resulted in loss of S-nitrosylation by NO (see below), modulation by Ca 2+ , calmodulin, oxygen tension or glutathione was not altered (49) . A likely explanation for these results is that alkylation of C3635 introduces major steric effects, whereas a C3635 to alanine substitution does not.
Dependence of RyR1 ion channel activity on free thiol content was determined by exploring the effects of three physiological determinants of cellular redox stateoxygen tension, reduced (GSH) or oxidized (GSSG) glutathione, and NO/O 2 -(released by SIN-1). Nearly half of the 404 cysteines within the tetrameric RyR1 channel complex were reduced (free thiol) in the presence of 5 mM GSH at pO 2~1 0 mm Hg, i.e. under conditions comparable to resting muscle (50) . Oxidation of ~10 RyR1 thiols (~48 to ~38 free thiols per RyR1 subunit) had little effect on channel activity. Channel activity increased reversibly as the number of free thiols was reduced to ~23 per subunit, whereas more extensive oxidation (~13 free thiols per subunit) inactivated the channel irreversibly. Thus, RyR1 has at least three functional classes of thiols: 1) a large group of functionally inert thiols that may protect RyR1 from oxidation under conditions of low oxidative stress in normal working muscle, 2) another large group of redox active thiols that controls channel response to conditions of moderate oxidative stress during extensive exercise, and 3) a group of thiols that may be susceptible to oxidative injury under extreme conditions.
Redox active species affected the activity of RyR2, with the release of endogenous CaM causing release of Ca 2+ from SR (51) . Direct binding studies indicated that the affinity of apoCaM and CaCaM binding to RyR1 is lower under oxidizing conditions, as determined in the presence of reduced or oxidized glutathione (39). CaMdependent RyR2 activity was also influenced by glutathione redox potential, although to a lesser extent than RyR1. Redox modulation of RyR3 activity by reactive oxgen species has not been systematically studied.
S-NITROSYLATION OF RYRS
Nitric oxide (NO) is a ubiquitous regulator of cell function. Mammalian tissues express three isoforms of nitric oxide synthase, known as endothelial (eNOS), neuronal (nNOS) and inducible (iNOS) nitric oxide synthases. In normal skeletal muscle the predominant isoform is nNOS, whereas in cardiac muscle, the major isoform is eNOS (52) . Both isoforms are targeted to sarcolemmal caveolea by caveolae structural protein caveolin. Immunolocalization of nNOS to isolated cardiac but not not skeletal muscle SR vesicles has been reported, suggesting a unique localization of nNOS to cardiac SR (53). iNOS is absent or very low in normal skeletal muscle and heart but may increase, depending on disease state (52) .
The mechanism of NO action in muscle is not well understood. NO activates guanylate cyclase, which accounts for some of its physiological effects. However, NO is also known to affect cellular functions involving Snitrosylation and oxidation of free thiols. Both RyR1 (45) and RyR2 (54) are endogenously S-nitrosylated, supporting that NO is a physiological modulator of skeletal and cardiac muscle excitation-contraction coupling (55) (56) (57) (58) (59, 60) and inhibitory (61) effects were reported, suggesting that NO and NO-related molecules modify the channel in multiple ways. In two studies, NOgenerating agents both activated and inhibited the RyR1 in lipid bilayers, depending on donor concentration, membrane potential, and the presence of channel agonists and other sufhydryl modifying reagents (62, 63) .
In vitro S-nitrosylation of RyR1 depends on O 2 tension and on whether NO or NO-generating molecules are used. NO S-nitrosylated RyR1 at physiologically relevant oxygen tension (pO 2 ~ 10 mm Hg) but not in ambient air (pO 2~1 50 mm Hg) (45), whereas the NOgenerating molecule NOC-12 S-nitrosylated RyR1 in an oxygen-independent manner (64) . Changes in oxygen tension oxidize/reduce as many as 6-8 thiols in each RyR1 subunit (45), which may explain the responsiveness of RyR1 to NO at tissue pO 2 but not ambient air. Site-directed mutagenesis studies demonstrated that at physiological O 2 concentrations, NO specifically S-nitrosylates Cys3635 out of ~50 free cysteines per RyR1 subunit (49) . C3635 is in the CaM binding domain of RyR1, which may explain why NO transduces its functional effect only in the presence of calmodulin (45). Thus, different cysteines within the channel appear to be responsible for the nitrosative and oxidative regulation of RyR1.
NO and NO-generating molecules were also reported to activate (59) and inactivate (65) RyR2. NO-related molecules S-nitrosylate and oxidize the cardiac RyR in ambient O 2 tension. S-nitrosylation and oxidation (2-3 and ~3 sites/RyR subunit, respectively) led to activation of single RyR2s that was reversed by the sulfhydryl reducing agent dithiothreitol, whereas oxidation of a greater number of thiols was not reversed by dithiothreitol (54) . The level of S-nitrosylation depended on channel conformation because it was reduced by the RyR inhibitor Mg 2+ . Thus, NO-related molecules affect the cardiac RyR via covalent modifications of thiol groups, leading to reversible or irreversible alteration of RyR2 ion channel activity. SNitrosylation of RyR2 was suggested to be physiologically significant in the normal heart (57, 58), whereas excess oxidation during periods of oxidative stress can lead to deleterious loss of control. NO may have a role in ischemia-reperfusion injury, however, its function is controversial, as both protective (66) and deleterious (67) effects were described.
Taken together, current evidence suggests that the effects of NO and NO-related molecules on the RyRs depend on the experimental conditions, including redox state, the presence of allosteric effectors of the RyRs and the identity of NO-related molecules. Future work needs to address the isoform and tissue specificity of interaction of the RyRs with NO and NO-related molecules, the molecular basis of this specificity, and as it relates to the role of NO in overall cellular function.
PHOSPHORYLATION OF RYRS
Endogenous kinases and phosphatases that phosphorylate and/or modulate RyR1 include cAMPdependent protein kinase A (PKA), calmodulin-dependent kinase II (CaMKII), and protein phosphatase 1 (68-73). Phosphorylation of Ser2843 by endogogenous kinases (74) and in vitro phosphorylation of Ser2843 by cAMP-, cGMPand CaM-dependent protein kinases (75) have been reported. However, the presence of additional phosphorylation sites is likely, as CaMKII also phosphorylated threonine residue(s). Functional studies comparing the effects of endogenous and exogenous kinases also support the presence of more than one phosphorylation site (69).
RyR2 forms a large multi-protein complex that includes PKA, protein phosphatases 1 and 2A (PP1 and PP2A), and anchoring proteins for PKA and PP1 and PPA2 that bind to RyR2 via leucine/isoleucine zipper motifs (73, 76) . Regulation of channel activity by additional protein kinases and phosphatases has been reported. These include CaMKII (77) (78) (79) , protein kinase C (PKC) isoforms α and β (79), and calcineurin (80). Guse et al. (81) described the transient tyrosine phosphorylation of a ryanodine receptor upon T cell stimulation.
In vitro phosphorylation of Ser2809 (corresponding to Ser2843 in RyR1) by CaMK activated the calmodulin-inhibited RyR ion channel isolated from cardiac muscle (77) . On the other hand, Takasago et al. (82) (78) found that phosphorylation removed channel blockade by Mg 2+ when either applying PKA or CaMK II. Furthermore, calmodulin was shown to block the channel in the dephosphorylated state, which was overcome by treatment with CaMK but not PKA. More recent studies indicate that PKA phosphorylation destabilizes the RyR2 in failing hearts. PKA dissociated FKBP12.6 from RyR2 and increased the appearance of subconductance states (76) . In failing hearts, reduced levels of PP1 and PPA2 in the RyR2 macromolecular complex rather than an increased PKA activity appeared to be responsible for RyR2 hyperphosphorylation and formation of "leaky" channels.
Protein kinases also influence SR Ca 2+ release through interactions with proteins that influence SR Ca 2+ release. The sarcolemmal voltage-dependent L-type Ca 2+ channel (DHPR), like RyR2, is phosphorylated by PKA, PKC and CaMK II. Phosphorylation of the SR Ca 2+ pump regulatory protein phospholamban indirectly increases RyR2 activity by elevating the SR Ca 2+ load and thereby RyR activity. Indeed in permeabilized cardiomyocytes, PKA activation increased RyR2 activity (measured as sparks) in wild-type but not mutant cells lacking phospholamban (84) . PKA activation caused no change in spark frequency in phospholamban-deficient cells, even though 32 P-phosphorylation was increased. These data challenge the results of Marks et al. (76) that extensive PKA-mediated phosphorylation of RyR2 leads to the formation of leaky RyR2 channels. A caveat in the study of Li et al. (84) is that the studies were done with cardiomyocytes isolated from normal hearts and the stoichiometry of RyR2 phosphorylation was not determined. Other potential targets are RyR associated proteins. Phosphorylation of skeletal muscle calsequestrin (85) , triadin (86) and sarcolumenin (87) has been reported. 
CONCLUSION
